FIELD: chemistry.
SUBSTANCE: invention relates to compounds of sulfonylhydroxamic acid of a general formula I which can be used as selective inhibitors of histone deacetylases (HDAC). In the general formula I, the ring A constitutes phenyl, naphthalenyl and benzothiophenyl; the ring B constitutes phenyl; R1 constitutes alkyl; R2, R3 constitute hydrogen, alkoxy, halogen, nitro, benzyloxy, phenyl, CF3; R4, R5, R6 constitute hydrogen; X=O. The invention also relates to a method of synthesis of the described compounds and use thereof as selective HDAC inhibitors.
EFFECT: achieved is synthesis of compound which can be used as selective HDAC inhibitor.
15 cl, 3 dwg, 3 tbl, 18 ex
Title | Year | Author | Number |
---|---|---|---|
TREATMENT METHOD | 2012 |
|
RU2621148C2 |
HETEROCYCLIC COMPOUNDS AS PRMT5 INHIBITORS | 2018 |
|
RU2797822C2 |
COMPOUNDS OF 1-CYANO-PYRROLIDINES AS USP30 INHIBITORS | 2016 |
|
RU2717238C2 |
METHOD OF OBTAINING HYDROXAMIC ACIDS, DERIVATIVES OF 2-ARYL-2.3-DIHYDROQUINAZOLIN-4(1H)-ONES | 2020 |
|
RU2744750C1 |
2,3-DIHYDRO-1H-INDEN-1-YL-2,7-DIAZASPIRO[3,5]NONANE DERIVATIVES AND USE THEREOF AS GHRELIN RECEPTOR ANTAGONISTS OR INVERSE AGONISTS | 2011 |
|
RU2524341C2 |
THIAZOLPYRIMIDINES | 2012 |
|
RU2610840C2 |
ACTIVE COMPOUNDS WITH RESPECT TO BROMO-DOMAINS | 2015 |
|
RU2743074C2 |
NOVEL 4-AMINO-N-HYDROXYBENZAMIDES AS HDAC INHIBITORS FOR TREATING CANCER | 2012 |
|
RU2591190C2 |
MODULATORS OF NUCLEAR RECEPTORS | 2016 |
|
RU2715897C2 |
AROMATIC 6,7-DISUBSTITUTED 3-QUINOLINECARBOXAMIDE DERIVATIVES, METHOD FOR PRODUCTION THEREOF (VARIANTS), PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND USE THEREOF IN DRUG MANUFACTURING | 2002 |
|
RU2281940C2 |
Authors
Dates
2021-05-31—Published
2018-08-06—Filed